274 related articles for article (PubMed ID: 29863727)
21. Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective.
Ainslie GR; Davis M; Ewart L; Lieberman LA; Rowlands DJ; Thorley AJ; Yoder G; Ryan AM
Lab Chip; 2019 Sep; 19(19):3152-3161. PubMed ID: 31469131
[TBL] [Abstract][Full Text] [Related]
22. Monitoring of Microphysiological Systems: Integrating Sensors and Real-Time Data Analysis toward Autonomous Decision-Making.
Young AT; Rivera KR; Erb PD; Daniele MA
ACS Sens; 2019 Jun; 4(6):1454-1464. PubMed ID: 30964652
[TBL] [Abstract][Full Text] [Related]
23. Liver Microphysiological Systems for Predicting and Evaluating Drug Effects.
Ribeiro AJS; Yang X; Patel V; Madabushi R; Strauss DG
Clin Pharmacol Ther; 2019 Jul; 106(1):139-147. PubMed ID: 30993668
[TBL] [Abstract][Full Text] [Related]
24. On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships.
McAleer CW; Pointon A; Long CJ; Brighton RL; Wilkin BD; Bridges LR; Narasimhan Sriram N; Fabre K; McDougall R; Muse VP; Mettetal JT; Srivastava A; Williams D; Schnepper MT; Roles JL; Shuler ML; Hickman JJ; Ewart L
Sci Rep; 2019 Jul; 9(1):9619. PubMed ID: 31270362
[TBL] [Abstract][Full Text] [Related]
25. Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective.
Ewart L; Fabre K; Chakilam A; Dragan Y; Duignan DB; Eswaraka J; Gan J; Guzzie-Peck P; Otieno M; Jeong CG; Keller DA; de Morais SM; Phillips JA; Proctor W; Sura R; Van Vleet T; Watson D; Will Y; Tagle D; Berridge B
Exp Biol Med (Maywood); 2017 Oct; 242(16):1579-1585. PubMed ID: 28622731
[TBL] [Abstract][Full Text] [Related]
26. Blood-brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood-central nervous system interface.
Phan DT; Bender RHF; Andrejecsk JW; Sobrino A; Hachey SJ; George SC; Hughes CC
Exp Biol Med (Maywood); 2017 Nov; 242(17):1669-1678. PubMed ID: 28195514
[TBL] [Abstract][Full Text] [Related]
27. A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies.
Phillips JA; Grandhi TSP; Davis M; Gautier JC; Hariparsad N; Keller D; Sura R; Van Vleet TR
Lab Chip; 2020 Feb; 20(3):468-476. PubMed ID: 31989145
[TBL] [Abstract][Full Text] [Related]
28. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
[TBL] [Abstract][Full Text] [Related]
29. Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development.
Hargrove-Grimes P; Low LA; Tagle DA
Cells Tissues Organs; 2022; 211(3):269-281. PubMed ID: 34380142
[TBL] [Abstract][Full Text] [Related]
30. Applications of microphysiological systems to disease models in the biopharmaceutical industry: Opportunities and challenges.
Irrechukwu O; Yeager R; David R; Ekert J; Saravanakumar A; Choi CK
ALTEX; 2023; 40(3):485-518. PubMed ID: 36648096
[TBL] [Abstract][Full Text] [Related]
31. Advanced Materials and Sensors for Microphysiological Systems: Focus on Electronic and Electrooptical Interfaces.
Kavand H; Nasiri R; Herland A
Adv Mater; 2022 Apr; 34(17):e2107876. PubMed ID: 34913206
[TBL] [Abstract][Full Text] [Related]
32. Critical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS).
Malik M; Yang Y; Fathi P; Mahler GJ; Esch MB
Front Cell Dev Biol; 2021; 9():721338. PubMed ID: 34568333
[TBL] [Abstract][Full Text] [Related]
33. Human iPSC-based cardiac microphysiological system for drug screening applications.
Mathur A; Loskill P; Shao K; Huebsch N; Hong S; Marcus SG; Marks N; Mandegar M; Conklin BR; Lee LP; Healy KE
Sci Rep; 2015 Mar; 5():8883. PubMed ID: 25748532
[TBL] [Abstract][Full Text] [Related]
34. A thermoplastic microfluidic microphysiological system to recapitulate hepatic function and multicellular interactions.
Bale SS; Manoppo A; Thompson R; Markoski A; Coppeta J; Cain B; Haroutunian N; Newlin V; Spencer A; Azizgolshani H; Lu M; Gosset J; Keegan P; Charest JL
Biotechnol Bioeng; 2019 Dec; 116(12):3409-3420. PubMed ID: 30963546
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi-MPS Integration.
Yu J; Cilfone NA; Large EM; Sarkar U; Wishnok JS; Tannenbaum SR; Hughes DJ; Lauffenburger DA; Griffith LG; Stokes CL; Cirit M
CPT Pharmacometrics Syst Pharmacol; 2015 Oct; 4(10):585-94. PubMed ID: 26535159
[TBL] [Abstract][Full Text] [Related]
36. Human biomimetic liver microphysiology systems in drug development and precision medicine.
Gough A; Soto-Gutierrez A; Vernetti L; Ebrahimkhani MR; Stern AM; Taylor DL
Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):252-268. PubMed ID: 33335282
[TBL] [Abstract][Full Text] [Related]
37. Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development.
Wright CB; Becker SM; Low LA; Tagle DA; Sieving PA
J Ocul Pharmacol Ther; 2020; 36(1):25-29. PubMed ID: 31166829
[TBL] [Abstract][Full Text] [Related]
38. [Pharma challenges to adoption of microphysiological system in drug research and development, especially safety assessment].
Naraoka H
Nihon Yakurigaku Zasshi; 2023; 158(2):187-192. PubMed ID: 36858504
[TBL] [Abstract][Full Text] [Related]
39. Microphysiological systems for human aging research.
Park S; Laskow TC; Chen J; Guha P; Dawn B; Kim DH
Aging Cell; 2024 Mar; 23(3):e14070. PubMed ID: 38180277
[TBL] [Abstract][Full Text] [Related]
40. Patient-Derived Microphysiological Systems for Precision Medicine.
Ko J; Song J; Choi N; Kim HN
Adv Healthc Mater; 2024 Mar; 13(7):e2303161. PubMed ID: 38010253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
